Francesco Raspagliesi, Oncologia Ginecologica [Gynaecological Oncology], Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan

In recent decades, new knowledge and the advent of novel diagnostic and therapeutic resources have made the approach to the management of patients with ovarian cancer increasingly complex¹. Ovarian cancer is biologically heterogeneous, and the sensitivity to treatment varies greatly from case to case².